Alkaline Earth Metal Salts
Apexbio Technology LLC Fenoprofen calcium hydrate 71720-56-4 10mM (in 1mL DMSO)
Fenoprofen calcium hydrate (CAS 71720-56-4) is a non-steroidal anti-inflammatory compound that acts by inhibiting cyclooxygenase (COX) enzymes leading to reduced synthesis of prostaglandins involved in inflammation and pain signaling By targeting COX-mediated pathways it is widely utilized in studies examining molecular mechanisms of inflammation pain modulation and prostaglandin biosynthesis This compound serves as a research tool in both in vitro and in vivo models to investigate the pharmacological modulation of inflammatory responses and evaluate novel anti-inflammatory therapeutic strategies
Apexbio Technology LLC Fenoprofen calcium hydrate 71720-56-4 1g
Fenoprofen calcium hydrate (CAS 71720-56-4) is a non-steroidal anti-inflammatory compound that acts by inhibiting cyclooxygenase (COX) enzymes leading to reduced synthesis of prostaglandins involved in inflammation and pain signaling By targeting COX-mediated pathways it is widely utilized in studies examining molecular mechanisms of inflammation pain modulation and prostaglandin biosynthesis This compound serves as a research tool in both in vitro and in vivo models to investigate the pharmacological modulation of inflammatory responses and evaluate novel anti-inflammatory therapeutic strategies
Apexbio Technology LLC Fenoprofen calcium hydrate 71720-56-4 5g
Fenoprofen calcium hydrate (CAS 71720-56-4) is a non-steroidal anti-inflammatory compound that acts by inhibiting cyclooxygenase (COX) enzymes leading to reduced synthesis of prostaglandins involved in inflammation and pain signaling By targeting COX-mediated pathways it is widely utilized in studies examining molecular mechanisms of inflammation pain modulation and prostaglandin biosynthesis This compound serves as a research tool in both in vitro and in vivo models to investigate the pharmacological modulation of inflammatory responses and evaluate novel anti-inflammatory therapeutic strategies
Medchemexpress LLC ENMD-1198 | 864668-87-1 | 98.9% | 311.42 | 100 MG
ENMD-1198 is an orally active microtubule destabilizing agent and a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity. It is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to reduced tumor growth and vascularization.
- Inhibits HIF-1alpha and STAT3.
- Reduces tumor growth.
- Reduces vascularization.
- Exhibits antiproliferative activity against human MDA-MB-231 cells.
- Inhibits HCC cell growth with IC50s of 2.5 μM for HUH-7 and HepG2 cells.
Medchemexpress LLC ENMD-1198 | 864668-87-1 | 98.48% | 311.42 | 1 ML
ENMD-1198 (IRC-110160) is an orally active microtubule destabilizing agent and a 2-methoxyestradiol analogue. It exhibits antiproliferative and antiangiogenic activity by inhibiting HIF-1alpha and STAT3 in human HCC cells, leading to reduced tumor growth and vascularization.
- Acts as a microtubule destabilizing agent.
- Shows antiproliferative and antiangiogenic activity.
- Inhibits HIF-1alpha and STAT3.
- Causes dose-dependent inhibition of HCC cell growth.
- Abrogates EGF-induced phosphorylation of key signaling proteins.
- Inhibits growth of hepatocellular carcinoma in xenograft models.
Medchemexpress LLC ENMD-1198 (IRC-110160) | 864668-87-1 | 98.87% | 311.42 | 5 MG
ENMD-1198 (IRC-110160) is an orally active microtubule destabilizing agent, which is a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity. It is effective in inhibiting HIF-1alpha and STAT3 in human HCC cells, leading to reduced tumor growth and vascularization.
- Orally active microtubule destabilizing agent.
- 2-methoxyestradiol analogue.
- Antiproliferative activity.
- Antiangiogenic activity.
- Inhibits HIF-1alpha and STAT3 in human HCC cells.
- Reduces tumor growth and vascularization.
- Inhibits HCC cell growth.
- Abrogates EGF-induced phosphorylation of Akt, FAK, p44/42 MAPK, and STAT3.
- Effectively inhibits growth of hepatocellular carcinoma and angiogenesis in vivo.